Tumors induced in C3H/HeJ mice by coal tar neutral subfractions /

Mode of access: Internet.

Facts about the nose and nasal irrigation /

Mode of access: Internet.

Ueber die Entstehung der Nasal-vocale im Altfranzösischen.

Inaug.-Diss.

An essay on the general method of treating cancerous tumors ... /

Mode of access: Internet.

Benign tumors in the third ventricle of the brain: diagnosis and treatment,

"Read in abstract form at the meeting of the American Neurological Soceity, Atlantic City, N.J., June 7, 1932."

Eight chirurgical treatises, on these followings heads : (viz), I. Of tumors : II. Of ulcers : III. Of diseases of the anus : IV. Of the King's evil ... /

Mode of access: Internet.

Eight chirurgical treatises, on these followings heads : (viz), I. Of tumors : II. Of ulcers : III. Of diseases of the anus : IV. Of the King's evil ... /

Mode of access: Internet.

Eight chirurgical treatises, on these followings heads : (viz), I. Of tumors : II. Of ulcers : III. Of diseases of the anus : IV. Of the King's evil ... /

Mode of access: Internet.

Comparison of 5th digit morphology behavior coding to stage of disease coding in the reporting of primary brain tumors.

At head of title: Illinois State Cancer Registry.

The principles of surgery, as they relate to wounds, ulcers, fistulæ, aneurisms, wounded arteries, fractures of the limbs, tumors, the operations of trepan and lithotomy. Also of the duties of the military and hospital surgeon.

Mode of access: Internet.

The pathology and surgical treatment of tumors,

Mode of access: Internet.

Diseases of the chest, throat and nasal cavities ..

Mode of access: Internet.

Primary tumors of the calvaria, with special consideration of the clinical problems

Mode of access: Internet.

Treatment of eight dogs with nasal tumours with a alternating doses of doxorubicin and carboplatin in conjunction with oral piroxicam

Objective To determine the efficacy and toxicity of chemotherapy in the treatment of canine nasal tumours. Design Retrospective clinical study Procedure Eight dogs with histologically confirmed nasal tumours were staged by means of complete blood count, serum biochemical analysis, cytological analysis of fine needle aspirate of the regional lymph nodes, thoracic radiographs and computed tomography scan of the nasal cavity. All dogs were treated with alternating doses of doxorubicin, carboplatin and oral piroxicam. All dogs were monitored for side effects of chemotherapy and evaluated for response to treatment by computed tomography scan of the nasal cavity after the first four treatments. Results Complete remission was achieved in four dogs, partial remission occurred in two dogs and two had stable disease on the basis of computed tomography evaluation. There was resolution of clinical signs after one to two doses of chemotherapy in all dogs. Conclusions This chemotherapy protocol was efficacious and well tolerated in this series of eight cases of canine nasal tumours.

Impaired Antigen Presentation and Effectiveness of Combined Active/Passive Immunotherapy for Epithelial Tumors

Background: Although immunization with tumor antigens can eliminate many transplantable tumors in animal models, immune effector mechanisms associated with successful immunotherapy of epithelial cancers remain undefined. Methods: Skin from transgenic mice expressing the cervical cancer-associated tumor antigen human papillornavirus type 16 (HPV16) E6 or E7 proteins from a keratin 14 promoter was grafted onto syngeneic, non-transgenic mice. Skin graft rejection was measured after active immunization with HPV16 E7 and adoptive transfer of antigen-specific T cells. Cytokine secretion of lymphocytes from mice receiving skin grafts and immunotherapy was detected by enzyme-linked immunosorbent assay, and HPV16 E7-specific memory CD8(+) T cells were detected by flow cytometry and ELISPOT. Results: Skin grafts containing HPV16 E6- or E7-expressing keratinocytes were not rejected spontaneously or following immunization with E7 protein and adjuvant. Adoptive transfer of E7-specific T-cell receptor transgenic CD8(+) T cells combined with immunization resulted in induction of antigen-specific interferon gamma-secreting CD8(+) T cells and rejection of HPV16 E7-expressing grafts. Specific memory CD8(+) T cells were generated by immunotherapy. However, a further HPV16 E7 graft was rejected from animals with memory T cells only after a second E7 immunization. Conclusions: Antigen-specific CD8(+) T cells can destroy epithelium expressing HPV16 E7 tumor antigen, but presentation of E7 antigen from skin is insufficient to reactivate memory CD8(+) T cells induced by immunotherapy. Thus, effective cancer immunotherapy in humans may need to invoke sufficient effector as well as memory T cells.